GE HEALTHC.TECH.INC. -,01
73,50€
-0,61 (-0,82%)
07.05.2024, 10:14:14 Uhr
WKN: A3D3G6 ISIN: US36266G1076 Wertpapiertyp: Aktie Währung: Euro
- 1T
- 1W
- 1M
- 3M
- 6M
- 1J
- 3J
- 5J
- 10J
- Max
Weltmärkte
- DAX ® +61,37 +0,34% 18.236,58
- MDAX ® +266,62 +1,01% 26.567,44
- TecDAX ® +25,52 +0,78% 3.291,74
- E-STOXX 50 ® +35,48 +0,72% 4.956,96
- NASDAQ 100 +202,77 +1,13% 18.093,57
- NIKKEI -49,86 -0,13% 38.811,22
- HANG SENG -111,13 -0,60% 18.479,37
Kursperformance
Zeitraum | Kurs | % |
---|---|---|
1 Tag | 74,11€ | -0,82% |
1 Woche | 80,88€ | -8,38% |
1 Monat | 82,46€ | -10,13% |
6 Monate | 67,20€ | +10,28% |
Lfd. Jahr (YTD) | 69,71€ | +6,31% |
1 Jahr | 72,63€ | +2,03% |
3 Jahre | -- | -- |
5 Jahre | -- | -- |
Kursdaten
Kurs | 73,50€ |
Schluss Vortag | 74,11€ |
Eröffnung | 73,69€ |
Geld | 73,51€ |
Brief | 74,09€ |
Tages-Hoch | 73,69€ |
Tages-Tief | 73,50€ |
52 Wochen-Hoch | 86,50€ |
52 Wochen-Tief | 58,50€ |
Allzeit-Hoch | 86,50€ |
Allzeit-Tief | 50,97€ |
Nachrichten
- BUSINESS WIRE: GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies - 02.11.2023, 13:00:09 Uhr
- BUSINESS WIRE: SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers - 11.10.2023, 14:00:54 Uhr
- BUSINESS WIRE: First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies - 15.06.2023, 08:00:06 Uhr